Search results

Metastatic, Non Small Cell Lung Cancer – further opinion

still think Erlotinib is a viable option especially if EGFR mutations are present. tags:  ...

Non Small Cell Lung cancer, Stage 4, S/P Right Pneumonectomy

in having his tumor tissue sent for assessment of EGFR and KRAS mutations , as well as for the EML4-alk translocation . A number for ...

JustAnswer.com